Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 3,309 shares at $20.08 ($66K) on 2020-05-29, disclosed to the SEC on 2020-06-01.
Scheduled sale ($66k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 1,919 | $38K | 57.9% |
| 2 | $20.08 | 1,390 | $28K | 42.1% |
| Total | $20.04 avg | 3,309 | $66K | 100% |
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |